Arsenate suppression of human keratinocyte programming

被引:30
作者
Kachinskas, DJ [1 ]
Qin, Q [1 ]
Phillips, MA [1 ]
Rice, RH [1 ]
机构
[1] UNIV CALIF DAVIS, DEPT ENVIRONM TOXICOL, DAVIS, CA 95616 USA
关键词
AP1; AP2; chromate; involucrin; phorbol ester; vanadate;
D O I
10.1016/S1383-5742(97)00015-X
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The human keratinocyte line SCC-9 has been used as a model for arsenate-induced perturbations of differentiation. Growth of these cells in 10 mu M arsenate permitted the cultures to reach confluence, but prevented expression of 6 markers of suprabasal differentiation (involucrin, loricrin, filaggrin, spr 1, keratin 1 and keratin 10) as assayed by Northern blotting. By contrast, only slight alterations in mRNA levels were observed for one differentiation marker (keratinocyte transglutami- nase) and for keratin 5, keratin 14, AP2 or glyceraldehyde phosphate dehydrogenase. The transition metal oxyanions vanadate and chromate had essentially the same suppressive effect on these markers as arsenate, while chronic treatment with tetradecanoylphorbol acetate was generally less effective in suppressing differentiation. To determine whether the previously observed arsenate-mediated alteration in AP1 and AP2 activities could account for the suppression of involucrin, a promoter analysis was conducted. Putative AP1 and AP2 response elements were identified in regions important for transcriptional activity of the 5'-flanking DNA. Mutations in two AP1 sites and one AP2 site were observed to decrease promoter activity significantly, and in combination, to reduce it to approximate to 10% of that conferred by the native sequence. These results lend support to the working hypothesis that arsenate suppresses involucrin expression, and, more generally, keratinocyte programming, by altering the transcription factors AP1 and AP2.
引用
收藏
页码:253 / 261
页数:9
相关论文
共 51 条
[41]   DIFFERENTIATION-ASSOCIATED EXPRESSION OF THE PROTOONCOGENE PIM-1 IN CULTURED HUMAN KERATINOCYTES [J].
STEWART, BE ;
RICE, RH .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 105 (05) :699-703
[42]   ANALYSIS OF THE 5'-UPSTREAM PROMOTER REGION OF HUMAN INVOLUCRIN GENE - ACTIVATION BY 12-O-TETRADECANOYLPHORBOL-13-ACETATE [J].
TAKAHASHI, H ;
IIZUKA, H .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 100 (01) :10-15
[43]  
TSENG WP, 1968, J NATL CANCER I, V40, P453
[44]   INGESTED ARSENIC AND INTERNAL CANCER - A HISTORICAL COHORT STUDY FOLLOWED FOR 33 YEARS [J].
TSUDA, T ;
BABAZONO, A ;
YAMAMOTO, E ;
KURUMATANI, N ;
MINO, Y ;
OGAWA, T ;
KISHI, Y ;
AOYAMA, H .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (03) :198-209
[45]   EVIDENCE FOR POSTTRANSCRIPTIONAL REGULATION OF THE KERATINS EXPRESSED DURING HYPERPROLIFERATION AND MALIGNANT TRANSFORMATION IN HUMAN-EPIDERMIS [J].
TYNER, AL ;
FUCHS, E .
JOURNAL OF CELL BIOLOGY, 1986, 103 (05) :1945-1955
[46]   FOS-RELATED ANTIGEN (FRA-1), JUNB, AND JUND ACTIVATE HUMAN INVOLUCRIN PROMOTER TRANSCRIPTION BY BINDING TO PROXIMAL AND DISTAL AP1 SITES TO MEDIATE PHORBOL ESTER EFFECTS OIL PROMOTER ACTIVITY [J].
WELTER, JF ;
CRISH, JF ;
AGARWAL, C ;
ECKERT, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (21) :12614-12622
[47]  
*WHO, 1980, IARC MON EV CARC RIS, P101
[48]   CLONING AND EXPRESSION OF AP-2, A CELL-TYPE-SPECIFIC TRANSCRIPTION FACTOR THAT ACTIVATES INDUCIBLE ENHANCER ELEMENTS [J].
WILLIAMS, T ;
ADMON, A ;
LUSCHER, B ;
TJIAN, R .
GENES & DEVELOPMENT, 1988, 2 (12A) :1557-1569
[49]  
YAMAMOTO S, 1995, CANCER RES, V55, P1271
[50]   CHROMIUM(VI)-INDUCED NUCLEAR FACTOR-KAPPA-B ACTIVATION IN INTACT-CELLS VIA FREE-RADICAL REACTIONS [J].
YE, JP ;
ZHANG, XY ;
YOUNG, HA ;
MAO, Y ;
SHI, XL .
CARCINOGENESIS, 1995, 16 (10) :2401-2405